On 26 May 2015
Suven Life Sciences will hold a meeting of the Board of Directors of the Company on 26 May 2015, to consider and approve the Audited Financial Results of the Company for the fourth quarter and year ended 31 March 2015, and to consider and recommend dividend if any, for the financial year 2014-15.Powered by Capital Market - Live News